Casey Vermoegensverwaltung EGBR takes one per cent stake in Duke Street Bio Limited

Published

Casey Vermoegensverwaltung EGBR entered Duke Street Bio Limited, a precision medicine biotech firm, with a one per cent E ordinary holding.

O’Kane Ventures Limited entered with a zero point four per cent E ordinary holding.

Alaia Holdings Limited entered with a zero point two per cent E ordinary holding.

The wider register grew, with other non-individual holders also adding E ordinary shares. Filed on 10 July 2026 for the two-year period ending 1 July 2026.

Shareholder data

Source: Companies House confirmation statement (CS01) — period to , filed .

Changes in this confirmation statement

TypeShareholderSharesChangeShare classes
New shareholderO'KANE VENTURES LIMITED2,400
E ORDINARY 2,400
New shareholderALAIA HOLDINGS LIMITED1,198
E ORDINARY 1,198
New shareholderDELONDRA ONCOLOGY LIMITED899
E ORDINARY 899
IncreasedMAP INVESTMENTGESELLSCHAFT AGMVK - MAP GLOBAL LIFE SCIENCES FUND I73,874+29%
D ORDINARY 57,407
E ORDINARY 16,467

Current shareholders (6)

ShareholderTotal sharesShare classes
MAP INVESTMENTGESELLSCHAFT AGMVK - MAP GLOBAL LIFE SCIENCES FUND I73,874
D ORDINARY 57,407
E ORDINARY 16,467
THAMES TEMESE MANAGEMENT LTD AS TRUSTEE OF THAMES TRUST68,063
D ORDINARY 65,069
E ORDINARY 2,994
SIGAL FAMILY INVESTMENTS LLC10,599
A ORDINARY 10,000
E ORDINARY 599
O'KANE VENTURES LIMITED2,400
E ORDINARY 2,400
ALAIA HOLDINGS LIMITED1,198
E ORDINARY 1,198
DELONDRA ONCOLOGY LIMITED899
E ORDINARY 899

Share this

Contact the editorial team at editorial@fundingspotter.com